Article
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
Strong Bearish
-100.0
−100 Bearish
0
+100 Bullish
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Nov 14, 2025 · 12:57 pm
Article ID
t5wo3qs
Original URL
Open source
Sentiment Signal
Strong Bearish
-100.0
−100Neutral+100
More Like This